dc.contributor.author | Rietschel, P. | |
dc.contributor.author | Pouliot, J. | |
dc.contributor.author | Lee, S. | |
dc.contributor.author | Seebach, F. | |
dc.contributor.author | Lowy, I. | |
dc.contributor.author | Gullo, G. | |
dc.contributor.author | Bondarenko, I. | |
dc.contributor.author | Sezer, A. | |
dc.contributor.author | Kilickap, S. | |
dc.contributor.author | GÜMÜŞ, MAHMUT | |
dc.contributor.author | ÖZGÜROĞLU, Mustafa | |
dc.contributor.author | Gogishvili, M. | |
dc.contributor.author | Turk, H. M. | |
dc.contributor.author | Cicin, I. | |
dc.contributor.author | Bentsion, D. | |
dc.contributor.author | Gladkov, O. | |
dc.contributor.author | Clingan, P. | |
dc.contributor.author | Sriuranpong, V. | |
dc.contributor.author | Rizvi, N. | |
dc.contributor.author | Mcginniss, J. | |
dc.date.accessioned | 2021-12-10T11:22:37Z | |
dc.date.available | 2021-12-10T11:22:37Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Bondarenko I., Sezer A., Kilickap S., GÜMÜŞ M., ÖZGÜROĞLU M., Gogishvili M., Turk H. M. , Cicin I., Bentsion D., Gladkov O., et al., "Clinical Benefit of First-Line Cemiplimab in Patients with Locally Advanced NSCLC: Subgroup Analysis from EMPOWER-Lung 1", JOURNAL OF THORACIC ONCOLOGY, cilt.16, sa.10, 2021 | |
dc.identifier.issn | 1556-0864 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_79ee8e48-2948-4265-ace9-152091eef525 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/171777 | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Göğüs Hastalıkları ve Allerji | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | Oncology | |
dc.subject | Respiratory Care | |
dc.subject | Pulmonary and Respiratory Medicine | |
dc.subject | Health Sciences | |
dc.subject | Klinik Tıp | |
dc.subject | SOLUNUM SİSTEMİ | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp (MED) | |
dc.title | Clinical Benefit of First-Line Cemiplimab in Patients with Locally Advanced NSCLC: Subgroup Analysis from EMPOWER-Lung 1 | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF THORACIC ONCOLOGY | |
dc.contributor.department | Dnipro State Medical University , , | |
dc.identifier.volume | 16 | |
dc.identifier.issue | 10 | |
dc.contributor.firstauthorID | 2770433 | |